MeCure Industries (NSA:MECURE) EV-to-EBITDA : (As of May. 24, 2025)

View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MeCure Industries's enterprise value is ₦0.00 Mil. MeCure Industries does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate MeCure Industries's EV-to-EBITDA at this moment.

The historical rank and industry rank for MeCure Industries's EV-to-EBITDA or its related term are showing as below:

NSA:MECURE's EV-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 13.625
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-24), MeCure Industries's stock price is ₦11.10. MeCure Industries does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate MeCure Industries's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

MeCure Industries EV-to-EBITDA Historical Data

The historical data trend for MeCure Industries's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries EV-to-EBITDA Chart

MeCure Industries Annual Data

Trend

EV-to-EBITDA

MeCure Industries Semi-Annual Data

EV-to-EBITDA

Competitive Comparison of MeCure Industries's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, MeCure Industries's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeCure Industries's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MeCure Industries's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MeCure Industries's EV-to-EBITDA falls into.

Save Embed

;

Save Embed

;

MeCure Industries EV-to-EBITDA Calculation

MeCure Industries's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	0.000	/
	=

MeCure Industries (NSA:MECURE) EV-to-EBITDA Explanation

MeCure Industries's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	11.10	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

MeCure Industries EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MeCure Industries's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

MeCure Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA

Website

https://www.mecure.com

MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines